FMT
SGNT

First Mercantile Trust’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

First Mercantile Trust’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,585
Closed -$41K – 1253
2014
Q2 		$41K Hold
1,585
– – ﹤0.01% 997
2014
Q1 		$37K Sell
1,585
-1,345
-46% -$29.4K ﹤0.01% 1118
2013
Q4 		$74K Sell
2,930
-1,175
-29% -$26.5K 0.01% 888
2013
Q3 		$84K Buy
+4,105
New +$91.4K 0.01% 851

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

First Mercantile Trust's SGNT Position: Q3 2014 in Review

First Mercantile Trust sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2014, closing a stake of 1,585 shares — an estimated $41K sold.

First Mercantile Trust first reported a position in SGNT in Q3 2013 and held it in 4 quarters. The position peaked at $84K in Q3 2013. 114 funds tracked by Wall St. Rank hold SGNT as of Q3 2014.

  • First Mercantile Trust reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • First Mercantile Trust sold 1,585 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $41K.
  • First Mercantile Trust first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 4 quarters.
  • First Mercantile Trust's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $84K in Q3 2013.
  • 114 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on First Mercantile Trust's 13F filing for Q3 2014, filed 12 Nov 2014.